Hangzhou Neoantigen Therapeutics Co., Ltd.
Hangzhou Neoantigen Therapeutics Co., Ltd.
Explore linked clinical trials.11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-04-01 | NCT07504523 | |
| Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection | Biliary Malignant Tumors | Recruiting | Phase 1 / Phase 2 | 2026-02-03 | NCT07368803 | |
| Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection | Resectable Esophageal Cancer | Active, not recruiting | Phase 1 | 2025-12-02 | NCT05307835 | |
| Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma (HCC) | Recruiting | Phase 1 / Phase 2 | 2025-08-14 | NCT07123545 | |
| Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma (HCC) | Recruiting | Phase 1 / Phase 2 | 2025-05-29 | NCT06995105 | |
| Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma | Advanced Intrahepatic Cholangiocarcinoma | Recruiting | Phase 1 / Phase 2 | 2025-05-04 | NCT06956716 | |
| Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer. | Pancreatic Cancer Resectable | Not yet recruiting | Phase 1 / Phase 2 | 2025-03-21 | NCT06888674 | |
| Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer. | Pancreatic Cancer Metastatic; Pancreatic Cancer Non-resectable | Not yet recruiting | Phase 1 / Phase 2 | 2025-03-21 | NCT06888648 | |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 1 | 2023-09-11 | NCT06026800 | |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 1 | 2023-09-11 | NCT06026774 | |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 1 | 2023-09-11 | NCT06019702 |